(MENAFN- PR Newswire) OSLO, Norway, Nov. 20, 2023 /PRNewswire/ -- Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces its participation in four investor conferences focusing on the healthcare sector in Q4 2023:
The SEB Healthcare Seminar
will take place in Stockholm, November 21-23, 2023. David Moskowitz, Photocure's Vice President Investor Relations will present a corporate overview on November 22 at 10:40am CET.
The 35th
Annual Piper Sandler Healthcare Conference
will be held in New York City, November 28-30, 2023. Dan Schneider, Photocure's President and CEO will present on November 28 at 9:50am ET. A webcast of the presentation will be available at:
Photocure ASA (PHO NO) - 1644046 (webcasts)
The 2023 Nordic American Healthcare Conference
is scheduled to be held
December 6-7 in New York City. Dan Schneider will present a corporate overview on December 6 at 2:30pm ET.
The 14th
Annual DNB Nordic Healthcare Conference
will be held in Oslo on December 14, 2023. Photocure's President and CEO Dan Schneider will present a corporate overview at 3:35pm CET.
For further information, please contact:
Dan Schneider
President and CEO
Photocure ASA
Email: [email protected]
Erik
Dahl
CFO
Photocure ASA
Tel: +4745055000
Email: [email protected]
David Moskowitz
Vice President, Investor Relations
Photocure ASA
Tel: +1 202 280 0888
Email: [email protected]
Media and IR enquiries:
Geir Bjørlo
Corporate Communications (Norway)
Tel: +47 91540000
Email: [email protected]
The following files are available for download:
MENAFN20112023003732001241ID1107459391
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.